INNOVATION
IN
NANOTECHNOLOGY

We develop solutions to unsolved problems of medicine with the use of unique patent-protected nanotechnology.
Our innovations focus on human blood substitutes and targeted cancer therapies.

ABOUT NANOGROUP

NEWS

NanoGroup
Nanogroup - nanotechnology for medicine

Nanovelos has been informed of the Chinese Patent Office’s intention to grant conditional ownership of the patent application.

Once the registration formalities are completed within the stipulated timeframe, the China Patent Office will decide whether to grant the patent right and then a Letters Patent will be issued by the aforementioned office confirming the registration and announcement. The subject of patent application CN 201980017745.X ” Antracycline encapsulated with polysaccharide for use in the […]

Nanogroup - nanotechnology for medicine

NanoGroup with 3 new sources of R&D funding

More than PLN 9 million – this is the total value of the financing that, under the agreement concluded between eCapital sp. z o.o. and NanoGroup S.A., the pending share issue and the investor offer received, may raise NanoGroup S.A. in the coming months. Funds from 3 different sources have, among other things. help a […]

Nanogroup - nanotechnology for medicine

Co-founder of Audioteka and eTutor believes in second life for NanoGroup

Michal Lach has bet millions on a WSE biotech group that recently came close to insolvency. NanoGroup is also supported by other investors. The entire article, by Mariusz Bartodziej, is worth reading in Puls Biznesu. Valued at over PLN 20 million on the WSE (at its peak, even several times higher), NanoGroup was in 2022. […]

MEDIA RESOURCES

MEDICINE OF TOMORROW

NanoGroup has two development pillars, both targeting critical unsolved medical needs.

ONGOING
PLANNED

RESPIRATORY GASES
EXCHANGE FLUIDS

DISRUPTIVE INNOVATIONS

NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES

EASY UPSCALING, LOWER RISK

RESPIRATORY GASES
EXCHANGE FLUIDS

DISRUPTIVE INNOVATIONS
LONG-TERM
One of the biggest unsolved of global medicine
SHORT-TERM
Disrupting change in transplantology

NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES

EASY UPSCALING, LOWER RISK
New treatment opportunities with reduced development risk
ONGOING
PLANNED
SEE MORE >

CAREER

Do you set yourself ambitious scientific goals? Do you want to take part in bio-tech and nano-tech medical projects?

NanoGroup is a platform of competence and specialists who share a believe that groundbreaking technologies responding to pressing global challenges can emerge and be developed in Poland.
If you want to join our team, go ahead to contact us!

JOIN OUR TEAM
Copyright © NanoGroup 2023

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.